Dr. Richard Michael Rubenstein, MD

Dr. Rubenstein practices at Skin and Cancer Associates in Tamarac, Florida.

Dr. Rubenstein's NPI, 1477558096, was assigned on June 20, 2005. Dr. Rubenstein graduated from VCU School of Medicine in 1981. Dr. Rubenstein holds Florida license ME53550.

Dr. Rubenstein's primary practice is Skin and Cancer Associates, at 7421 N University Dr, Tamarac, FL 33321 in Broward County. The practice phone is (954) 473-6750.

Dr. Rubenstein's primary practice is Skin and Cancer Associates in Tamarac, Florida. The medical group on file is Skin and Cancer Associates. Dmand AI also links Dr. Rubenstein to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rubenstein practices. Vendor and product names are available with a free account.

Dermatology is Dr. Rubenstein's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Rubenstein is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Rubenstein's licenses on file in 4 states: Florida, New Jersey, New York and Illinois.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and facial skin infection among the conditions Dr. Rubenstein treats.

CMS data shows 9,467 Medicare services from Dr. Rubenstein across 25 procedure codes in 2024, for 1,676 Medicare patients. Medicare paid $450,115 for them. Every service was in an office.

CMS counts 1,676 Medicare patients who saw Dr. Rubenstein in 2024. The largest group is 75 to 84, with 717 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rubenstein's median patient age at 65, with 57% women.

In 2024, Dr. Rubenstein wrote 1,529 Medicare Part D claims for 638 patients. 93% of them were for generic drugs. CMS names the drug for 1,333 of them, across 29 drugs with 11 or more claims each, at $195,866 in total drug cost. In 2023, CMS named 1,261 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Rubenstein for performance year 2024, reported individually. Dr. Rubenstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 985 procedures of skin biopsy by Dr. Rubenstein, more than 99% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Rubenstein in 2020. Dr. Rubenstein's most frequent co-authors are Brad P. Glick, MD, Matthew R. Moore, MD and Yvette Arlene Tivoli, DO.

CMS Open Payments shows 611 general payments to Dr. Rubenstein from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 85% of the total. Novartis Pharmaceuticals Corporation paid the most, $2,175.

Dmand AI lists 3 awards for Dr. Rubenstein, most recently Gulfstream FL-Broward in 2013.

Dr. Rubenstein graduated from VCU School of Medicine in 1981. Dr. Rubenstein is a member of AAD.

Dr. Rubenstein is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.